Inhibition of cardiac hypertrophy by probiotic-fermented purple sweet potato yogurt in spontaneously hypertensive rat hearts

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1365-1375

  Lin, Pei Pei ^a   Hsieh, You Miin ^a   Kuo, Wei Wen ^b   Lin, Chien Chung ^c   Tsai, Fuu Jen ^b   Tsai, Chang Hai ^d   Huang, Chih Yang ^b,e,g   Tsai, Cheng Chih ^f  

^a Providence University   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c Armed Forces General Hospital   (China)

^d ASIA UNIVERSITY   (Japan)

^e ASIA UNIVERSITY   (Taiwan)

^f HUNGKUANG UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cardiac hypertrophy; Fermented yogurt; Hypertension; Lactic acid bacteria; aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID; ATRIAL NATRIURETIC FACTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CAPTOPRIL; CARDIOVASCULAR AGENT; MITOGEN ACTIVATED PROTEIN KINASE 7; PROBIOTIC AGENT; PROBIOTIC FERMENTED PURPLE SWEET POTATO YOGURT; UNCLASSIFIED DRUG; YOGHURT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXCISION; FERMENTED PRODUCT; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SWEET POTATO; WESTERN BLOTTING;

EID: 84869475438     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1154     Document Type: Article

References (43)

1. Kuo WW, Chu CY, Wu CH, Lin JA, Liu JY, Hsieh YH, Ueng KC, Lee SD, Hsieh DJ, Hsu HH, et al: Impaired IGF-signalling of hypertrophic hearts in the developmental phase of hypertension in genetically hypertensive rats. Cell Biochem Funct 23: 325-331, 2005. (Pubitemid 41330286)
2. Towbin JA and Bowles NE: The failing heart. Nature 415: 227-233, 2002. (Pubitemid 34059529)
3. Deblois D, Tea BS, Beaudry D and Hamet P: Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage. Can J Physiol Pharmacol 83: 29-41, 2005. (Pubitemid 40754773)
4. Kjeldsen SE, Dahlof B, Devereux RB, Julius S, Aurup Edelman J, et al: Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 288: 1491-1498, 2002.
5. Huang CY, Hao LY and Buetow DE: Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium-channel- dependent. Mol Cell Biochem 231: 51-59, 2002. (Pubitemid 34257222)
6. Lee SD, Chu CH, Huang EJ, Lu MC, Liu JY, Liu CJ, Hsu HH, Lin JA, Kuo WW and Huang CY: Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am J Physiol Endocrinol Metab 291: E306-E314, 2006. (Pubitemid 44035290)
7. Molkentin JD, Lu JR, Antos CL, et al: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998. (Pubitemid 28180855)
8. Wilkins B, De Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF and Molkentin JD: Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophy growth. Mol Cell Biol 22: 7603-7613, 2002.
9. Komatsuzaki N, Nakamura T, Kimura T and Shima Characterization of glutamate decarboxylase from a high gamma-aminobutyric acid (GABA)-producer, Lactobacillus paracasei. Biosci Biotechnol Biochem 72: 278-285, 2008.
10. Li H and Cao Y: Lactic acid bacterial cell factories for gamma-aminobutyric acid. Amino Acids 39: 1107-1116, 2010.
11. Ueno Y, Hayakawa K, Takahashi S and Oda K: Purification and characterization of glutamate decarboxylase from Lactobacillus brevis IFO 12005. Biosci Biotechnol Biochem 61: 1168-1171, 1997. (Pubitemid 127473041)
12. Kim JY, Lee MY, Ji GE, Lee YS and Hwang KT: Production of gamma-aminobutyric acid in black raspberry juice during fermentation by Lactobacillus brevis GABA100. Int J Food Microbiol 130: 12-16, 2009.
13. Denner LA and Wu JY: Two forms of rat brain glutamic acid decarboxylase differ in their dependence on free pyridoxal phosphate. J Neurochem 44: 957-965, 1985. (Pubitemid 15110066)
14. Oh SH, Choi WG, Lee IT and Yun SJ: Cloning and characterization of a rice cDNA encoding glutamate decarboxylase. Biochem Mol Biol 38: 595-601, 2005.
15. Yokoyama S, Hiramatsu J and Hayakawa K: Production of gamma-aminobutyric acid from alcohol distillery lees by Lactobacillus brevis IFO-12005. J Biosci Bioeng 93: 95-97, 2002.
16. Hayakawa K, Kimura M, Kasaha K, Matsumoto K, Sansawa and Yamori Y: Effect of a gamma-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Nutr 92: 411-417, 2004. (Pubitemid 40277062)
17. Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M and Sansawa H: Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 57: 490-495, 2003. (Pubitemid 36395684)
18. Yamakoshi J, Fukuda S, Satoh T, Tsuji R, Saito M, Obata A, Matsuyama A, Kikuchi M and Kawasaki T: Antihypertensive and natriuretic effects of less-sodium soy sauce containing gamma-aminobutyric acid in spontaneously hypertensive rats. Biosci Biotechnol Biochem 71: 165-173, 2007. (Pubitemid 46155160)
19. Philpott M, Lim CC and Ferguson LR: Dietary protection against free radicals: A case for multiple testing to establish structure-activity relationships for antioxidant potential of anthocyanic plant species. Int J Mol Sci 10: 1081-103, 2009.
20. Philpott M, Gould KS, Lim C and Ferguson LR: In situ and in vitro antioxidant activity of sweetpotato anthocyanins. Agric Food Chem 52: 1511-1513, 2004.
21. Konczak-Islam I, Yoshimoto M, Hou DX, Terahara N and Yamakawa O: Potential chemopreventive properties of anthocyanin-rich aqueous extracts from in vitro produced tissue of sweet potato (Ipomoea batatas L.). J Agr Food Chem 51: 5916-5922, 2003.
22. de Pascual-Teresa S, Moreno DA and García-Viguera C: Flavanols and anthocyanins in cardiovascular health: A review of current evidence. Int J Mol Sci 11: 1679-1703, 2010.
23. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T and Namba M: Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98: 794-799, 1998. (Pubitemid 28391845)
24. Li HL, Wang AB, Huang Y, Liu DP, Liu G, Zhang CN, Wei C, Liu YQ, Hui RT and Liang CC: Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 38: 243-257, 2005. (Pubitemid 39656135)
25. Li HL, Huang Y, Zhang CN, Liu G, Wei YS, Wang AB, Liu YQ, Hui RT, Wei C, Williams GM, et al: Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med 40: 1756-1775, 2006.
26. Wu TY, Tsai CC, Hwang YT and Chiu TH: Effect of antioxidant activity and functional properties of Chingshey purple sweet potato fermented milk by Lactobacillus acidophilus, L. delbrueckii subsp. lactis, and L. gasseri strains. J Food Sci 77: M2-M8, 2012.
27. Deschamps AM and Spinale FG: Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc Res 69: 666-676, 2006. (Pubitemid 43139729)
28. Kang PM and Izumo S: Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med 9: 177-182, 2003. (Pubitemid 36626707)
29. Heineke J and Molkentin JD: Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600, 2006. (Pubitemid 44325350)
30. Liu CF, Tung YT, Wu CL, Lee BH, Hsu WH and Pan TM: Antihypertensive effects of Lactobacillus-fermented milk orally administered to spontaneously hypertensive rats. J Agric Food Chem 59: 4537-4543, 2011.
31. Nishikimi T, Maeda N and Matsuoka H: The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69: 318-328, 2006. (Pubitemid 43098788)
32. Chu CH, Tzang BS, Chen LM, Kuo CH, Cheng YC, Chen LY, Tsai FJ, Tsai CH, Kuo WW and Huang CY: IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Gαq interaction and protein kinase C-α/CaMKII activation in H9c2 cardiomyoblast cells. J Endocrinol 197: 381-390, 2008. (Pubitemid 351696251)
33. Huang CY, Hao LY and Buetow DE: Hypertrophy of cultured adult rat ventricular cardiomyocytes induced by antibodies against the insulin-like growth factor (IGF)-I or the IGF-I receptor is IGF-II-dependent. Mol Cell Biochem 233: 65-72, 2002. (Pubitemid 34746111)
34. Okamura H, Aramburu J and Garcia-Rodriguez C, et al: Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell 6: 539-550, 2000.
35. Lim HW and Molkentin JD: Calcineurin and human heart failure. Nat Med 5: 246-247, 1999.
36. Kanda T and Takahashi T: Interleukin-6 and cardiovascular diseases. Jpn Heart J 45: 183-193, 2004. (Pubitemid 41518900)
37. Meléndez GC, McLarty JL, Levick SP, Du Y, Janicki JS and Brower GL: Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56: 225-231, 2010.
38. Hirano T: Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16: 249-284, 1998.
39. Hirota H, Yoshida K, Kishimoto T and Taga T: Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92: 4862-4866, 1995.
40. Nicol RL, Frey N, Pearson G, Cobb M, Richardson J and Olson EN: Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 20: 2757-2767, 2001. (Pubitemid 32938559)
41. Cameron SJ, Itoh S, Baines CP, Zhang C, Ohta S, Che W, Glassman M, Lee JD, Yan C, Yang J and Abe J: Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusion. FEBS Lett 566: 255-260, 2004. (Pubitemid 38625968)
42. Kimura M, Hayakawa K and Sansawa H: Involvement of γ-aminobutyric acid (GABA) B receptors in the hypotensive effect of systemically administered GABA in spontaneously hypertensive rats. Jpn J Pharmacol 89: 388-394, 2002. (Pubitemid 35021653)
43. Lin MY and Yen CL: Antioxidative ability of lactic acid bacteria. J Agric Food Chem 47: 1460-1466, 1999.